In vivo and in vitro techniques for comparative study of antiviral T-cell responses in the amphibian Xenopus

被引:0
|
作者
Heidi Morales
Jacques Robert
机构
[1] University of Rochester Medical Center,Department of Microbiology and Immunology
来源
关键词
Xenopus laevis; ranavirus; T-Lymphocytes;
D O I
暂无
中图分类号
学科分类号
摘要
Activation of lymphocytes in mammals is often quantified by measuring the amount of proliferation during the expansion phase of an immune response. Bromodeoxyuridine (BrdU) incorporation and carboxyfluorescein diacetate succinimidyl ester (CFSE) dilution assays are some of the techniques widely used in mammalian studies of pathogeninduced proliferation and provide a convenient way of quantifying the cellular response. We have extended the use of these proliferation assays to the amphibian Xenopus laevis. We have developed this species as a valuable comparative model to study immunity against a wellknown amphibian pathogen, Frog Virus 3 (FV3). Fluorescence activated cell sorting was used to assess the level of BrdU incorporation of lymphocytes in vivo and CFSE dilution in an in vitro activation assay. Both techniques have shown that splenic lymphocytes proliferate specifically upon FV3 challenge. This indicates that common methods for detection of proliferation upon immunologic challenge are easily applied to other vertebrate species, as it highlights the evolutionary conservation of the proliferative nature of immune responses throughout vertebrate phyla.
引用
收藏
页码:1 / 8
页数:7
相关论文
共 50 条
  • [1] In vivo and in vitro techniques for comparative study of antiviral T-cell responses in the amphibian Xenopus
    Morales, Heidi
    Robert, Jacques
    BIOLOGICAL PROCEDURES ONLINE, 2008, 10 (1) : 1 - 8
  • [2] Azodicarbonamide inhibits T-cell responses in vitro and in vivo
    Tassignon, J
    Ismaili, J
    Le Moine, A
    Van Laethem, F
    Leo, O
    Vandevelde, M
    Goldman, M
    NATURE MEDICINE, 1999, 5 (08) : 947 - 950
  • [3] Azodicarbonamide inhibits T-cell responses in vitro and in vivo
    Joël Tassignon
    Jamila Ismaili
    Alain Le Moine
    François Van Laethem
    Oberdan Leo
    Michel Vandevelde
    Michel Goldman
    Nature Medicine, 1999, 5 : 947 - 950
  • [4] Antiviral memory T-cell responses in the lung
    Woodland, DL
    Ely, KH
    Crowe, SR
    Tighe, M
    Brennan, JW
    Harmsen, AG
    Cauley, LS
    MICROBES AND INFECTION, 2002, 4 (10) : 1091 - 1098
  • [5] IN-VITRO AND IN-VIVO MODULATION OF T-CELL RESPONSES IN FILARIASIS
    SARTONO, E
    KRUIZE, YCM
    KURNAWIAN, A
    MAIZELS, RM
    SELKIRK, ME
    VANDENELSEN, PJ
    EGGERMOND, MCJA
    YAZDANBAKHSH, M
    PARASITE, 1994, 1 : 17 - 18
  • [6] Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
    Joseph N. Blattman
    Jason M. Grayson
    E. John Wherry
    Susan M. Kaech
    Kendall A. Smith
    Rafi Ahmed
    Nature Medicine, 2003, 9 : 540 - 547
  • [7] Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo
    Blattman, JN
    Grayson, JM
    Wherry, EJ
    Kaech, SM
    Smith, KA
    Ahmed, R
    NATURE MEDICINE, 2003, 9 (05) : 540 - 547
  • [8] MHC RESTRICTION OF T-CELL PROLIFERATIVE RESPONSES IN XENOPUS
    HARDING, FA
    FLAJNIK, MF
    COHEN, N
    DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 1993, 17 (05): : 425 - 437
  • [9] ARE T-CELL RESPONSES IN THE FROG, XENOPUS, MHC RESTRICTED
    HARDING, F
    WATKINS, D
    COHEN, N
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 225 - 225
  • [10] Lenalidomide enhances myeloma-specific T-cell responses in vivo and in vitro
    Kraemer, Isabelle
    Engelhardt, Melanie
    Fichtner, Sabrina
    Neuber, Brigitte
    Medenhoff, Sergej
    Bertsch, Uta
    Hillengass, Jens
    Raab, Marc-Steffen
    Hose, Dirk
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Hundemer, Michael
    ONCOIMMUNOLOGY, 2016, 5 (05):